Junghof, Julia https://orcid.org/0000-0002-2674-4361
Kogure, Yuta
Yu, Tian
Verdugo-Sivianes, Eva MarĂa https://orcid.org/0000-0002-0922-0371
Narita, Megumi https://orcid.org/0000-0002-8198-4042
Lucena-Cacace, Antonio https://orcid.org/0000-0002-1181-2683
Yoshida, Yoshinori https://orcid.org/0000-0001-5511-9090
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP19bm0804008, JP20bm0204003, JP20bm0804022, JP19mk0104117, JP19bk0104095, JP19bm0104001)
MEXT | Japan Society for the Promotion of Science (17H04176, 21H02912, 20K17078)
Fondation Leducq (18CVD05)
iPS Cell Research Fund, SECOM Science and Technology Foundation
Article History
Received: 2 March 2021
Accepted: 20 December 2021
First Online: 2 February 2022
Competing interests
: J.J., T.Y., Y.K., E.M.V.-S., M.N. and A.L.-C. declare no competing interest. Y.Y. is a scientific advisor of Orizuru Therapeutics.